Investor update
Shareholder Information
Shares In Issue
As at 09 December 2022, the number of shares in issue was 91,190,661.
Significant Shareholders
As at 09 December 2022, significant shareholders that hold more than 3% of the share capital of OptiBiotix Health Plc, and shareholdings of any other directors are detailed below:
Number | Ordinary Shares % | |
Stephen O'Hara (Director) | 10,212,986 | 11.19 |
Finance Yorkshire Seedcorn Fund (FYSCF) | 9,449,314 | 10.36 |
Stephen O'Hara holds 6,099,135 shares under Option
Directors' Shareholders
Number | Ordinary Shares % | |
Stephen O'Hara (Director) | 10,212,986 | 11.19 |
Neil Davidson (Director) | 503,000 | 0.55 |
Sean Christie (Director) | 150,000 | 0.16 |
Rene Kamminga | 55,844 | 0.06 |
Stephen Hammond | 50,000 | 0.05 |
Shares not in Public hands
In the terms of the AIM Rules and insofar as it is aware, at 21 November 2022, 23.2% of the Company's AIM securities was not in public hands.
Restrictions in transfer of AIM securities
There are no restrictions on the transfer of OptiBiotix Health Plc's AIM securities.
Other exchanges and trading platforms
OptiBiotix Health Plc has not applied or agreed to have any of it securities (including its AIM securities) admitted or traded on any other exchanges or trading platforms.
Shareholder Circulars
26 July 2022 | Results of the Proxy votes for the AGM held on 26 July 2022 |
28 June 2022 | Notice of Annual General Meeting held on 26 July 2022 |
09 July 2021 | Shareholders Q&As from the AGM held on 09 July 2021 |
17 June 2021 | Notice of Annual General Meeting held on 09 July 2021 |
Proxy for the Annual General Meeting held on 09 July 2021 | |
09 July 2020 | Results of the Proxy votes for the AGM held on 09 July 2020 |
Shareholders Q&As from the AGM held on 09 July 2020 | |
18 June 2020 | Notice of Annual General Meeting held on 09 July 2020 |
Proxy for the Annual General Meeting held on 09 July 2020 | |
17 May 2019 | Notice of Annual General Meeting held on 11 June 2019 |
Proxy for use at the Annual General Meeting held on 11 June 2019 | |
11 June 2018 | Notice of Annual General Meeting held on 4 July 2018 |
Proxy for use at the Annual General Meeting held on 4 July 2018 | |
Proposed New Articles of Association | |
08 January 2018 | Notice of General Meeting held on 25 January 2018 |
Proxy for use at the General Meeting held on 25 January 2018 | |
25 April 2017 | Notice of Annual General Meeting held on 15 June 2017 |
Proxy for use at the Annual General Meeting held on 15 June 2017 | |
14 April 2016 | Notice of Annual General Meeting held on 10 May 2016 |
29 May 2015 | Notice of Annual General Meeting held on 11 August 2015 |
23 July 2014 | Notice of General Meeting held on 04 August 2014 |
Form of Proxy for General Meeting held on 04 August 2014 | |
30 January 2014 | Notice of Annual General Meeting held on 24 February 2014 |
Form of Proxy for General Meeting held on 24 February 2014 | |
31 November 2013 | Notice of General Meeting held on 18 November 2013 |
UK City Code on Takeovers and Mergers
As an AIM traded UK registered company, OptiBiotix Health Plc is subject to the UK City Code on Takeovers and Mergers legislation.
Page last updated: 09 December 2022
Latest Video
ProBiotix Health anticipating "big commercial opportunities" during 2023
Group CEO Stephen O’Hara and CEO Steen Anderson | 04 January 2023
www.proactiveinvestors.co.uk
Latest Podcast
Stephen OHara interview with Investors Champion
Stephen O'Hara | 04 Jul 2019
www.investorschampion.com